ADRENAL
In critically ill patients with septic shock, does hydrocortisone compared with placebo, reduce 90 day mortality?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
In critically ill patients with septic shock, does hydrocortisone compared with placebo, reduce 90 day mortality?
Continue reading »In Zambian adults with sepsis and hypotension, does a resuscitation protocol implemented early after presentation to the Emergency Department improve in-hospital mortality compared with usual care?
Continue reading »In patients with refractory vasodilatory shock does the addition of angiotensin II improve blood pressure compared with standard vasopressor therapy?
Continue reading »In patients undergoing cardiac surgery with left ventricular dysfunction, does levosimendan compared to placebo reduce mortality?
Continue reading »Does intravenous vitamin C, hydrocortisone and thiamine in addition to standard treatment, improve mortality in ICU patients with severe sepsis or septic shock, compared with standard treatment alone?
Continue reading »In patients with severe sepsis does hydrocortisone compared to placebo prevent the development of septic shock?
Continue reading »Does early vasopressin use reduce the risk of kidney failure in patients with septic shock compared with norepinephrine?
Continue reading »In paediatric patients with septic shock, does adrenaline compared with dopamine reduce 28 day mortality?
Continue reading »In adult patients with septic shock, does early goal-directed therapy (EGDT) compared with standard therapy reduce mortality at 90 days?
Continue reading »In patients with acute kidney injury (AKI) and severe sepsis or septic shock, does extended daily haemofiltration (EDHF) compared with continuous venovenous haemofiltration (CVVHF) reduce time to renal recovery or mortality at 60 days?
Continue reading »